APA (7th ed.) Citation

AT, F., BCB, M., DGD, S., WL, G., RMP, M., LW, T., . . . M, L. (2025). Mechanistic Advances in the Therapeutic Application of Bixin for Lung Inflammation In Vitro and In Vivo. Pharmaceuticals (Basel, Switzerland), 18(4), . https://doi.org/10.3390/ph18040530

Chicago Style (17th ed.) Citation

AT, Figueiredo-Junior, Marques BCB, Santos DGD, Gouveia WL, Meza RMP, Tinoco LW, Lima LM, Valenca SS, and Lanzetti M. "Mechanistic Advances in the Therapeutic Application of Bixin for Lung Inflammation In Vitro and In Vivo." Pharmaceuticals (Basel, Switzerland) 18, no. 4 (2025). https://doi.org/10.3390/ph18040530.

MLA (9th ed.) Citation

AT, Figueiredo-Junior, et al. "Mechanistic Advances in the Therapeutic Application of Bixin for Lung Inflammation In Vitro and In Vivo." Pharmaceuticals (Basel, Switzerland), vol. 18, no. 4, 2025, https://doi.org/10.3390/ph18040530.